| 5 | IntegrinsIBA
01/2021
-
09/2010 |
| 2 | Peptides (Polypeptides)IBA
10/2020
-
08/2013 |
| 2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2019
-
01/2011 |
| 2 | dinutuximabIBA
01/2011
-
10/2007 |
| 2 | Immunoconjugates (Immunoconjugate)IBA
01/2011
-
10/2007 |
| 2 | eicosaneIBA
01/2011
-
10/2007 |
| 2 | Chelating AgentsIBA
01/2011
-
10/2007 |
| 2 | DiaminesIBA
01/2011
-
10/2007 |
| 2 | RadiopharmaceuticalsIBA
03/2009
-
10/2007 |
| 1 | Colloids (Colloid)IBA
11/2022 |
| 1 | OxidesIBA
11/2022 |
| 1 | PolymersIBA
11/2022 |
| 1 | Dopamine (Intropin)FDA LinkGeneric
09/2021 |
| 1 | Radioisotopes (Radionuclides)IBA
02/2021 |
| 1 | Therapeutic UsesIBA
02/2021 |
| 1 | InterferonsIBA
01/2021 |
| 1 | GlycolipidsIBA
01/2019 |
| 1 | ImmunoproteinsIBA
03/2016 |
| 1 | Immunoglobulin Fab FragmentsIBA
03/2016 |
| 1 | SodiumIBA
03/2016 |
| 1 | Dextrans (Dextran)FDA Link
03/2016 |
| 1 | Deoxyglucose (2 Deoxy D glucose)IBA
02/2014 |
| 1 | EstersIBA
11/2013 |
| 1 | triphenyltetrazoliumIBA
11/2013 |
| 1 | rhodamine BIBA
11/2013 |
| 1 | diethylene glycolIBA
11/2013 |
| 1 | CilengitideIBA
08/2013 |
| 1 | technetium 99m NC 100692IBA
08/2013 |
| 1 | cyclic arginine-glycine-aspartic acid peptideIBA
08/2013 |
| 1 | NC100692IBA
08/2013 |
| 1 | Complement System Proteins (Complement)IBA
11/2012 |
| 1 | triazacyclononaneIBA
01/2011 |
| 1 | AcidsIBA
01/2011 |
| 1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2011 |
| 1 | integrin beta7IBA
09/2010 |
| 1 | ProteomeIBA
04/2010 |
| 1 | NAD (NADH)IBA
04/2010 |
| 1 | OximesIBA
03/2009 |
| 1 | LigandsIBA
03/2009 |
| 1 | furanIBA
03/2009 |
| 1 | Monoclonal AntibodiesIBA
10/2007 |
| 1 | sialogangliosidesIBA
10/2007 |
